SCHEMBL22680902

SCHEMBL22680902

CC(C)(C)c1ccc(N2CCC3(CC2)COC3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
LMNA P02545 3/20 0.46
PRKDC P78527 1/20 0.42
HSD11B1 P28845 5/20 0.41
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RORC P51449 1/20 0.40
MAPK1 P28482 2/20 0.40
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17665015 0.81 ADRB1 (0.48) MAPTALDH1A1RORCMAPK1NPC1
SCHEMBL24124025 0.80 HSD11B1 (0.41) MAPTLMNAHSD11B1ALDH1A1MAPK1
SCHEMBL16437268 0.79 MAPT (0.45) MAPTLMNAPRKDCHSD11B1ALDH1A1
SCHEMBL24123997 0.79 CYP2D6 (0.63) HSD11B1ALDH1A1SMN1; SMN2MAPK1USP2
SCHEMBL270272 0.78 MAPT (0.65) MAPTLMNAPRKDCHSD11B1ALDH1A1
SCHEMBL20178041 0.78 HSD11B1 (0.57) MAPTLMNAPRKDCHSD11B1ALDH1A1
SCHEMBL25018482 0.78 LRRK2 (0.46) MAPTLMNAPRKDCHSD11B1ALDH1A1
SCHEMBL15400584 0.77 AKR1C3 (0.46) MAPTLMNAALDH1A1RORCMAPK1
SCHEMBL14320393 0.77 MAPT (0.50) MAPTLMNAALDH1A1SMN1; SMN2RORC
SCHEMBL4403156 0.77 HSD11B1 (0.47) MAPTLMNAPRKDCHSD11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200361924-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361924-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES FTH1, SLC40A1, FECH MAPT 2107/4885LMNA 4703/4885PRKDC 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.